/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n\n \n \n \n\n \n \n \n
\n\n \n
\n  Recent News: Keryx Biopharmaceuticals Inc.
\n \n \n\n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n \n\n \n\n \n \n \n\n
02/05/10 
3:59 PM EST 
\n \n \n Keryx Biopharmaceuticals (NASDAQ: KERX) Responds to Erroneous Report About Planned Phase III Study for Patients With Colorectal Cancer - Marketwire\n \n
02/05/10 
6:51 AM EST 
\n \n \n Biopharmaceutical Stock Alert for Keryx Biopharmaceuticals Inc. Issued by InvestorSoup - GlobeNewswire\n \n
02/03/10 
8:30 AM EST 
\n \n \n Keryx Biopharmaceuticals Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of KRX-0401 (Perifosine) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer - PR Newswire\n \n
02/02/10 
8:30 AM EST 
\n \n \n Keryx Biopharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference - PR Newswire\n \n
01/29/10 
8:30 AM EST 
\n \n \n Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results of Perifosine as a Single Agent for the Treatment of Advanced Waldenstrom's Macroglobulinemia - PR Newswire\n \n
\n
\n \n\n\n\n\n\n
Feb 10 12:17 AM EST
\n\n\n\n \n
\n\n");